AstraZeneca, HealthCore CER Collaboration Will Look at Genomically Defined Subpopulations
February 16, 2011
AstraZeneca, HealthCore CER Collaboration Will Look at Genomically Defined Subpopulations
"The breadth of data that will be available through the collaboration will also support studies of sub-populations, some of which may be genetically defined," an AstraZeneca spokesperson said.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Aurora to Use Oracle's Informatics Muscle to Run More Efficient Clinical Trials; PGx in Long View
February 9, 2011 / Pharmacogenomics Reporter - Aridhia, Pivotal Collaborate on Stratified Medicine Informatics
May 2, 2013 / GenomeWeb Daily News - Oxford Cancer Biomarkers Developing CDx Biomarkers for AstraZeneca
April 16, 2013 / GenomeWeb Daily News - Foundation Medicine, AstraZeneca to ID Genetic Mutations for Cancer Drug Development
November 12, 2012 / GenomeWeb Daily News - Protein Interaction Study Bolsters Case for HER3 as Major Player in Cancer Development
September 14, 2012 / ProteoMonitor